Compare NSP & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSP | ENOV |
|---|---|---|
| Founded | 1986 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Fluid Controls |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 1997 | 2008 |
| Metric | NSP | ENOV |
|---|---|---|
| Price | $38.55 | $26.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $47.67 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 910.8K | 804.1K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | ★ 6.24% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $6,757,000,000.00 | $2,233,266,000.00 |
| Revenue This Year | $4.71 | $9.27 |
| Revenue Next Year | $6.40 | $4.56 |
| P/E Ratio | $85.99 | ★ N/A |
| Revenue Growth | 3.19 | ★ 11.57 |
| 52 Week Low | $31.00 | $25.47 |
| 52 Week High | $95.98 | $49.38 |
| Indicator | NSP | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 57.67 | 36.46 |
| Support Level | $34.14 | $26.49 |
| Resistance Level | $36.32 | $28.27 |
| Average True Range (ATR) | 1.32 | 1.15 |
| MACD | 0.84 | -0.15 |
| Stochastic Oscillator | 90.83 | 6.43 |
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.